The latest prostate cancer news
Prostate cancer blood test with 94% accuracy
Researchers at the University of East Anglia in the UK have develop a new blood…
Browsing: Prostate Cancer
Neuronal molecule makes prostate cancer more aggressive
Prostate cancer is the second most common cancer and the second leading cause of cancer…
Aussie cancer gene discovery: new lung cancer treatments
Scientists from The Australian National University (ANU) and the Peter MacCallum Cancer Centre have discovered that a protein, called Menin, contributes to abnormal deactivation of…
Combined PET and MRI scans for prostate cancer protein predict recurrence
In men recently diagnosed with intermediate or high-grade prostate cancer, prostate specific membrane antigen (PSMA)…
MRI-guided radiotherapy produces fewer side effects and better quality of life for patients with localised prostate cancer
For men who undergo radiotherapy for localised prostate cancer, the precise targeting capabilities of MRI…
Prostate cancer trial testing therapy based on molecular discovery
A new prostate cancer therapy in clinical trials could treat patients resistant to treatment through…
New hormonal agent may slow progression of early-stage prostate cancer during active surveillance
For men with early-stage prostate cancer being managed by active surveillance, adding the hormonal agent…
New prostate cancer diagnostic pathway paves way for general screening
In screening for prostate cancer, the risk of overdiagnosis can be halved, a University of…
ESMO ASIA 2022: Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment
More than 1.4 million men were diagnosed with prostate cancer in 2020 globally(1), but the…
Treatment without hormone blockers improves outcomes in solitary prostate cancer metastases
For patients with solitary metastases from prostate cancer, an approach called metastasis-directed therapy (MDT) –…